Retreatment of Sensitive SCLC Feasible
(MedPage Today) -- Retreatment of locally relapsed small-cell lung cancer (SCLC) with platinum-containing chemotherapy significantly prolonged progression-free survival (PFS) as compared with topotecan, a randomized trial showed.
Patients who...
Read more »